Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Clinical efficacy of tamsulosin and tadalafil in distal urethral stone passage: A randomized clinical trial

Zahraa Nasser Abdul Ghani1 , Hayder Abdulhafedh Kurji2, Inas Sami Ali3, Wisam Ghazi Sanad4

1Department of Pharmacology & Physiology, College of Pharmacy, University of Al Mashreq, Baghdad,; 2Department of Clinical Pharmacy,; 3Department of Pharmaceutical Chemistry, College of Pharmacy, University of Bilad Alrafidain, Diyala,; 4Department of Pharmaceutics, College of Pharmacy, Al-Zahraa University for Women, Karbala, Iraq.

For correspondence:-  Zahraa Ghani   Email: zahraa.naaser.a@uom.edu.iq

Received: 24 March 2026        Accepted: 18 June 2025        Published: 29 June 2026

Citation: Ghani ZN, Kurji HA, Ali IS, Sanad WG. Clinical efficacy of tamsulosin and tadalafil in distal urethral stone passage: A randomized clinical trial. Trop J Pharm Res 2026; 25(6):865-870 doi: https://dx.doi.org/10.4314/tjpr.v25i6.12

© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the efficacy of tamsulosin in combination with tadalafil compared to tamsulosin alone in distal ureteral stones. Methods: A total of 80 adult patients with single distal ureteral stones (5–12 mm) were included in this randomized open-label study. The patients were randomly and equally assigned into study and control groups. Study group (n = 40) received tamsulosin (0.4 mg) plus tadalafil (5 mg) daily, and control group received (n = 40) received tamsulosin (0.4 mg) alone. Follow-up was done for 20 days, and clinical parameters such as stone expulsion rate, time of expulsion, frequency of pain episodes, analgesic requirements, and side effects were compared between both groups. Categorical data were compared using chi-square test. Measurement data were compared using the independent sample t-test. P < 0.05 was considered statistically significant Results: Stone expulsion rate was significantly higher, and mean stone expulsion time was significantly shorter in study group compared to control (p < 0.05). Furthermore, patients in study group experienced significantly fewer pain episodes and required analgesics less frequently (p < 0.05). Adverse effects were milder with no significant difference between the groups (p > 0.05), with no major complications. Conclusion: Tadalafil in combination with tamsulosin significantly increases expulsion rate, accelerates stone expulsion, reduces pain and analgesic use in patients with distal ureteral calculi without any significant increase in side effects.

Keywords: Distal ureteral stones, Medical expulsive therapy, Tadalafil, Tamsulosin, Urolithiasis

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal: